Cure Ventures Fund I, L.P. is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Apr 4, 2023, it has sold $350,456,853 of interests to 44 investors since its first sale in May 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Richard Lim; Cure Ventures Fund I GP, LLC; Louis Tartaglia.
- Total raised
- $350,456,853Cumulative sales reported on Form D
- Investors
- 44
- First sale
- May 25, 2021
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Richard Lim; Cure Ventures Fund I GP, LLC; Louis Tartaglia
- Latest Form D
- Apr 4, 2023
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Apr 4, 2023 | Form D/A (amendment) | $350,456,853 | 44 | SEC.gov ↗ |
| May 20, 2022 | Form D/A (amendment) | $207,868,020 | 25 | SEC.gov ↗ |
| May 24, 2021 | Form D | $0 | 0 | SEC.gov ↗ |
3 Form D filings in the SEC's electronic records (2008 onward), the earliest on May 24, 2021. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about Cure Ventures Fund I, L.P.
What is the minimum investment for Cure Ventures Fund I, L.P.?
Cure Ventures Fund I, L.P.'s latest Form D, filed Apr 4, 2023, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Cure Ventures Fund I, L.P.?
Cure Ventures Fund I, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Cure Ventures Fund I, L.P. raised?
Cure Ventures Fund I, L.P. reports $350,456,853 sold from 44 investors on its Form D filed Apr 4, 2023. This is cumulative sales since the offering began, not current assets or performance.
Where is Cure Ventures Fund I, L.P. based?
Cure Ventures Fund I, L.P. is based in Boston, Massachusetts.
When did Cure Ventures Fund I, L.P. launch?
Cure Ventures Fund I, L.P. reports its first sale in May 2021.
Size compared with every venture capital fund
Raised more than 98% of the 533 venture capital funds based in Massachusetts, and more than 99% of all 14,876 that report sales.